Are you Dr. Cook?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 90 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3181 Sw Sam Jackson Park Rd
Portland, OR 97239Phone+1 503-494-8426- Is this information wrong?
Summary
- Dr. Rachel Cook, MD is a hematologist in Portland, Oregon. She is currently licensed to practice medicine in Oregon, Hawaii, and Wisconsin. She is affiliated with OHSU Hospital.
Education & Training
- University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 2006 - 2009
- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2002 - 2006
- Loyola University Chicago Stritch School of MedicineClass of 2002
Certifications & Licensure
- OR State Medical License 2013 - 2025
- HI State Medical License 2023 - 2024
- WI State Medical License 2009 - 2013
- PA State Medical License 2006 - 2010
- MN State Medical License 2003 - 2006
- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011
Publications & Presentations
PubMed
- 1 citationsUse of tamibarotene, a potent and selective RARα agonist, in combination with azacitidine in patients with relapsed and refractory AML withgene overexpression.Eytan M Stein, Stephane de Botton, Thomas Cluzeau, Arnaud Pigneux, Jane L Liesveld, Rachel J Cook, Philippe Rousselot, David A Rizzieri, Thorsten Braun, Gail J Roboz, ...> ;Leukemia & Lymphoma. 2023 Dec 1
- Day 4 collection of granulocyte colony-stimulating factor-mobilized HLA-matched sibling donor peripheral blood allografts demonstrates no long-term increase in chronic...Georgeann Booth, Yun Yu, Rogelyn P Harlan, Carol E Jacoby, Kaitlyn M Tomic, Susan E Slater, Bryon E Allen, Elizabeth M Berklich, Rebekah J Knight, Julieann Dela Cruz, ...> ;Cytotherapy. 2023 Apr 1
- 12 citationsTargeting RARA overexpression with tamibarotene, a potent and selective RARα agonist, is a novel approach in AML.Stéphane de Botton, Thomas Cluzeau, Carlos Vigil, Rachel J Cook, Philippe Rousselot, David A Rizzieri, Jane L Liesveld, Pierre Fenaux, Thorsten Braun, Anne Banos, Jose...> ;Blood Advances. 2023 May 9
- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
- OHSU HospitalPortland, Oregon